|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 405/14 | |||
| C07D 413/14 | |||
| C07D 401/04 | |||
| C07D 413/04 | |||
| C07D 417/04 | |||
| C07D 241/42 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/4375 | |||
| A61P 37/00 |
| (11) | Number of the document | 3390389 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16840344.2 |
| Date of filing the European patent application | 2016-12-16 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/067112 |
| Date | 2016-12-16 |
| (87) | Number | WO 2017/106607 |
| Date | 2017-06-22 |
| (30) | Number | Date | Country code |
| 201562268765 P | 2015-12-17 | US | |
| 201662353603 P | 2016-06-23 | US |
| (72) |
SHERER, Brian A., US
BRUGGER, Nadia, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS |
| POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS |